337 related articles for article (PubMed ID: 16875716)
21. Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.
Soh J; Rositch AF; Koutsky L; Guthrie BL; Choi RY; Bosire RK; Gatuguta A; Smith JS; Kiarie J; Lohman-Payne B; Farquhar C
Int J STD AIDS; 2014 Apr; 25(5):315-24. PubMed ID: 24047885
[TBL] [Abstract][Full Text] [Related]
22. [Usefulness of Hybrid Capture II detection of high-risk human papillomavirus in women with abnormal pap-smears of the uterine cervix].
Tena D; Garrido N; Menéndez JM; Delgado JJ; Romanyk J; González Mdel R; Zapico A; Beltrán M
Enferm Infecc Microbiol Clin; 2005 Oct; 23(8):474-8. PubMed ID: 16185561
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
[TBL] [Abstract][Full Text] [Related]
24. Colpocytological abnormalities in HIV infected and uninfected pregnant women: prevalence, persistence and progression.
Carriero C; Fascilla FD; Cramarossa P; Lepera A; Bettocchi S; Vimercati A
J Obstet Gynaecol; 2018 May; 38(4):526-531. PubMed ID: 29390909
[TBL] [Abstract][Full Text] [Related]
25. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
[TBL] [Abstract][Full Text] [Related]
26. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?
Atashili J; Adimora AA; Ndumbe PM; Ikomey GM; Rinas AC; Myers E; Eron J; Smith JS; Miller WC
Cancer Epidemiol; 2012 Jun; 36(3):263-9. PubMed ID: 22047636
[TBL] [Abstract][Full Text] [Related]
28. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
[TBL] [Abstract][Full Text] [Related]
29. HPV-based cervical cancer screening in a population at high risk for HIV infection.
Womack SD; Chirenje ZM; Gaffikin L; Blumenthal PD; McGrath JA; Chipato T; Ngwalle S; Munjoma M; Shah KV
Int J Cancer; 2000 Jan; 85(2):206-10. PubMed ID: 10629079
[TBL] [Abstract][Full Text] [Related]
30. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.
Bateman AC; Katundu K; Mwanahamuntu MH; Kapambwe S; Sahasrabuddhe VV; Hicks ML; Chi BH; Stringer JS; Parham GP; Chibwesha CJ
BMC Cancer; 2015 Jul; 15():541. PubMed ID: 26205980
[TBL] [Abstract][Full Text] [Related]
31. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group.
Rezza G; Giuliani M; Branca M; Benedetto A; Migliore G; Garbuglia AR; D'Ubaldo C; Pezzotti P; Cappiello G; Pomponi Formiconi D; Suligoi B; Schiesari A; Ippolito G; Giacomini G
Eur J Epidemiol; 1997 Dec; 13(8):937-43. PubMed ID: 9476825
[TBL] [Abstract][Full Text] [Related]
32. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India.
Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM
Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
[TBL] [Abstract][Full Text] [Related]
34. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
[TBL] [Abstract][Full Text] [Related]
35. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
Heard I; Schmitz V; Costagliola D; Orth G; Kazatchkine MD
AIDS; 1998 Aug; 12(12):1459-64. PubMed ID: 9727566
[TBL] [Abstract][Full Text] [Related]
36. [A comparison of human papillomavirus detection and ThinPrep cytology test for women in Guangdong province].
Xue YH; Chen ZX; Zheng BW; Zhang JM; Zhu QY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):283-5. PubMed ID: 15996320
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
[TBL] [Abstract][Full Text] [Related]
38. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
[TBL] [Abstract][Full Text] [Related]
39. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.
Madeddu G; Mameli G; Capobianco G; Babudieri S; Maida I; Bagella P; Rocca G; Cherchi PL; Sechi LA; Zanetti S; Nunnari G; Dessole S; Mura MS
Eur Rev Med Pharmacol Sci; 2014; 18(8):1277-85. PubMed ID: 24817305
[TBL] [Abstract][Full Text] [Related]
40. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
